Podcasts

MDedge Daily News: Improving wearable cardioverter defibrillators

Publish date: March 12, 2018

 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Closer tailoring might boost wearable cardioverter defibrillators’ benefit, alirocumab cuts deaths in post–acute coronary syndrome patients, the ODYSSEY Outcomes trial redefines secondary cardiovascular prevention, and how walking cuts postmenopausal women’s heart failure risk.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Heart attacks soar in young IBD patients
MDedge Cardiology
Postmenopausal women: Walk farther and faster to reduce heart failure risk
MDedge Cardiology
VEST: Closer tailoring might boost wearable cardioverter defibrillator’s benefit
MDedge Cardiology
ODYSSEY Outcomes results build on FOURIER
MDedge Cardiology
ODYSSEY Outcomes trial redefines secondary cardiovascular prevention
MDedge Cardiology
Ticagrelor noninferior to clopidogrel in terms of major bleeds in STEMI
MDedge Cardiology
Genotype did not significantly affect evacetrapib response
MDedge Cardiology
CECCY: Carvedilol didn’t curb cardiotoxicity in breast cancer patients
MDedge Cardiology